Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Journal of Internal Medicine|August 29, 2023
Precision cancer medicine: Concepts, current practice, and future developmentsAnders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Cancers|July 14, 2023
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain TumorsMathieu Chicard, Yasmine Iddir, Julien Masliah Planchon, et al.
Blood|October 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphomaElif Karaca Atabay, Carmen Mecca, Qi Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTSJordane Chaix, Gudrun Schleiermacher, Nadège Corradini, et al.
Plos One|March 6, 2012
Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomasStephanie Puget, Cathy Philippe, Dorine A Bax, et al.
EMBO Molecular Medicine|July 15, 2024
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cellsJeremy Rich, Melanie Bennaroch, Laura Notel, et al.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
Pediatric Blood & Cancer|September 21, 2021
Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcomaPascale Varlet, Eric Bouffet, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2013
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyAngela Di Giannatale, Nathalie Dias-Gastellier, Annick Devos, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
Pageof 19